Oligospermia due to radiation
ICD-10 N46.124 is a billable code used to indicate a diagnosis of oligospermia due to radiation.
Oligospermia due to radiation refers to a condition characterized by a lower than normal sperm count in the ejaculate, specifically resulting from exposure to radiation. This exposure can occur due to various medical treatments, such as radiation therapy for cancer, which can adversely affect the testicular tissue and sperm production. The condition is significant as it can lead to male infertility, impacting a man's ability to conceive. The pathophysiology involves damage to the seminiferous tubules, where sperm production occurs, leading to impaired spermatogenesis. Symptoms may not be overt, but the diagnosis is often made through semen analysis, which reveals a sperm count below 15 million sperm per milliliter. Management of oligospermia due to radiation may involve andrological interventions, including assisted reproductive technologies, hormonal therapy, or sperm retrieval techniques. Understanding the implications of radiation exposure on male reproductive health is crucial for effective treatment and counseling.
Detailed history of radiation exposure, semen analysis results, and any treatments attempted.
Patients presenting with infertility concerns post-radiation therapy.
Consideration of other testicular disorders that may coexist.
Records of radiation treatment plans and dosages, as well as follow-up fertility assessments.
Patients undergoing treatment for malignancies who are concerned about fertility.
Coordination with urology for fertility preservation options.
Used to evaluate sperm count in patients with suspected oligospermia.
Results of semen analysis must be documented in the patient's record.
Urologists often perform this procedure as part of fertility evaluations.
The primary cause is damage to the testicular tissue due to radiation exposure, which impairs sperm production.
